Related Experiment Video
Updated: May 15, 2025
07:32
Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
Published on: June 15, 2012
26.6K
Efficient and Discriminative Isolation of Circulating Cancer Stem Cells and Non-Stem-like Circulating Tumor Cells
Huida Li1, Fengting Jia1, Xin Wang1
1Research Center for Analytical Sciences, Department of Chemistry, College of Sciences, Northeastern University, Box 332, Shenyang 110819, China.
Analytical Chemistry
|April 7, 2025
Summary
Researchers developed a novel method to isolate rare circulating cancer stem cells (cCSCs) from blood samples. This technique improves the detection of metastasis-driving cells, advancing cancer research and precision medicine.
Area of Science:
- Oncology
- Biotechnology
- Nanotechnology
Background:
- Circulating tumor cells (CTCs) are vital in cancer research, with circulating cancer stem cells (cCSCs) driving metastasis and therapy resistance.
- Current methods struggle to efficiently isolate and distinguish cCSCs from non-stem-like CTCs (nsCTCs), limiting cancer progression studies.
Purpose of the Study:
- To develop a novel approach for efficient isolation and selective capture of cCSCs and nsCTCs from blood samples.
- To overcome limitations in current CTC isolation techniques for better understanding cancer metastasis and resistance.
Main Methods:
- Developed CHPhace: a method integrating cell metabolic chemical tagging with M13 phage-based surfaces.
- Utilized flexible M13 nanofibers with numerous modification sites for enhanced CTC capture.
- Leveraged cCSC slow-cycling characteristics for selective isolation via metabolic labeling and demetabolism.
Main Results:
- CHPhace demonstrated efficient isolation of both cCSCs and nsCTCs from complex blood matrices.
- Achieved CTC capture efficiencies exceeding 80% across diverse tumor types.
- Successfully distinguished cCSCs from nsCTCs based on metabolic activity.
Conclusions:
- The CHPhace approach offers a promising tool for advancing cancer progression research.
- This method enhances precision in clinical diagnosis and cancer prognosis by enabling better CTC analysis.
- Improved isolation of cCSCs and nsCTCs facilitates deeper understanding of metastasis and therapeutic resistance mechanisms.
